Wed, Oct 22, 2014, 1:33 AM EDT - U.S. Markets open in 7 hrs 57 mins


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • betthepharm betthepharm May 15, 2013 6:59 PM Flag

    Class Action Suit

    Re the "House of Cards" & "Enrollment Figures Disappear" topics.
    I couldn't agree more with the comments. At the first stumble this company will almost certainly receive a visit from Coughlin Stoia, Labatons or one of the other major CAS lawyers.
    Ask Aveo or KV Pharma's shareholders how quickly fortunes can change when you keep sailing to close to the wind.

    Personally I think immunotherapy is the next big thing however I'll stick with Celldex who if anything don't sail close enough to the wind BUT will almost certainly never have a CAS to deal with.

    There are just too many questions arising from ImmunoCellular when you do your due diligence. Pushing out the previous CEO was an opportunity to make changes but they seem just as invested in these questionable practices as they were before. Perhaps management is hoping for a Celgene to come along & buy them out but I think if guys like me have problems with the company then I can't imagine they'd pass muster with big pharma / big bio.

    There's only one play here & most people on this board won't like me saying what it is...........GLTA

    Sentiment: Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.7119-0.0032(-0.45%)Oct 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.